Timucin Altin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timucin Altin has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Ömer Akyürek
Department of Cardiology Ankara University Ankara Turkey
26 shared publications - Basar Candemir
Department of Cardiology Ankara University Ankara Turkey
18 shared publications - Cetin Erol
Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Türkiye
15 shared publications - Mustafa Kilickap
Department of Cardiology, Ankara University Faculty of Medicine, Ankara, Turkey
12 shared publications - Emir Baskovski
Department of Cardiology Ankara University Ankara Turkey
11 shared publications - Cansin Tulunay Kaya
Cardiology Department, Ankara University School of Medicine, Ankara, Turkey
7 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7015
Left Atrial Appendage Occlusion vs. Oral Anticoagulants: Current Evidence and Debates
Atrial fibrillation (AF) is a major cause of cardioembolic stroke, and oral anticoagulation (OAC) remains the standard of care for thromboembolic prophylaxis. Because the left atrial appendage (LAA) is the dominant source of thrombus in AF, percutaneous LAA occlusion (LAAO) has been developed as a mechanical alternative for patients in whom long-term anticoagulation is problematic. Randomized trials against warfarin established non-inferiority for the composite endpoint, though not consistently across coprimary endpoints, and more recent trials against direct oral anticoagulants (DOACs) have extended this comparison to post-ablation and lower-risk populations. Across these studies a consistent pattern emerges: the clinical advantage of LAAO derives largely from a reduction in non-procedural bleeding rather than from superior ischemic protection, and recent meta-analyses diverge mainly according to how the thromboembolic endpoint is composed. At the extreme of stroke and bleeding risk, LAAO failed to demonstrate non-inferiority to physician-directed medical care. This review synthesizes the randomized evidence, examines methodological differences in endpoint construction and patient selection that complicate cross-trial comparison, and discusses determinants of procedural success including peridevice leak, device endothelialization, and device-related thrombus. Remaining evidence gaps are outlined, particularly for patients who experience ischemic stroke despite adequate anticoagulation.
- 10 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7015
Open AccessLeft Atrial Appendage Occlusion vs. Oral Anticoagulants: Current Evidence and Debates
Atrial fibrillation (AF) is a major cause of cardioembolic stroke, and oral anticoagulation (OAC) remains the standard of care for thromboembolic prophylaxis. Because the left atrial appendage (LAA) is the dominant source of thrombus in AF, percutaneous LAA occlusion (LAAO) has been developed as a mechanical alternative for patients in whom long-term anticoagulation is problematic. Randomized trials against warfarin established non-inferiority for the composite endpoint, though not consistently across coprimary endpoints, and more recent trials against direct oral anticoagulants (DOACs) have extended this comparison to post-ablation and lower-risk populations. Across these studies a consistent pattern emerges: the clinical advantage of LAAO derives largely from a reduction in non-procedural bleeding rather than from superior ischemic protection, and recent meta-analyses diverge mainly according to how the thromboembolic endpoint is composed. At the extreme of stroke and bleeding risk, LAAO failed to demonstrate non-inferiority to physician-directed medical care. This review synthesizes the randomized evidence, examines methodological differences in endpoint construction and patient selection that complicate cross-trial comparison, and discusses determinants of procedural success including peridevice leak, device endothelialization, and device-related thrombus. Remaining evidence gaps are outlined, particularly for patients who experience ischemic stroke despite adequate anticoagulation.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
Tricuspid Valve Function After Add-On Pacing/Sensing Lead vs ICD Lead Implantation for Failed IS-1/DF-1 ICD Leads: A Single-Center Experience
Background: The development or progression of tricuspid regurgitation (TR) following the implantation of cardiac implantable electronic devices (CIED) represents a significant concern. Although the link between transvalvular lead placement and TR is well established, the patient-related and lead-related factors that predispose patients to develop TR remain unclear. This study aimed to evaluate the effect of additional pacing/sensing leads (PSL) or implantable cardioverter defibrillator (ICD) leads on tricuspid valve function in patients with lead failure. Methods: In this retrospective, single-center, case-control study, all ICD implantation patients, in cases performed by one of these authors, presenting with lead failure were screened. The degree of TR on pre- and post-procedural echocardiograms of patients who underwent additional PSL or ICD lead implantation is compared. Results: The study comprised a total of 52 patients; 28 patients received PSL, and 24 patients received ICD electrodes. A non-significant increase in the degree of TR was observed in patients who underwent new ICD lead implantation (P = .059). The degree of TR observed in patients who underwent new PSL implantation was found to be comparable to the pre-procedure levels (P = .180). However, no statistically significant differences were observed between the 2 groups with respect to change in TR degree (P = .123). Conclusion: This study is the first analysis comparing the effect of ICD electrode addition with PSL addition without lead extraction on right ventricular and tricuspid valve function in patients with lead failure. This study provides the first comparative analysis of PSL versus ICD lead addition in patients with lead failure. The findings suggest that additional leads, whether PSL or ICD, do not significantly worsen tricuspid valve function. The addition of PSL to the IS-1/DF-1 ICD lead with standard high-voltage leads may be a viable treatment option, as it yields similar results to a new ICD lead implantation in terms of right heart function.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
Tricuspid Valve Function After Add-On Pacing/Sensing Lead vs ICD Lead Implantation for Failed IS-1/DF-1 ICD Leads: A Single-Center Experience
Background: The development or progression of tricuspid regurgitation (TR) following the implantation of cardiac implantable electronic devices (CIED) represents a significant concern. Although the link between transvalvular lead placement and TR is well established, the patient-related and lead-related factors that predispose patients to develop TR remain unclear. This study aimed to evaluate the effect of additional pacing/sensing leads (PSL) or implantable cardioverter defibrillator (ICD) leads on tricuspid valve function in patients with lead failure. Methods: In this retrospective, single-center, case-control study, all ICD implantation patients, in cases performed by one of these authors, presenting with lead failure were screened. The degree of TR on pre- and post-procedural echocardiograms of patients who underwent additional PSL or ICD lead implantation is compared. Results: The study comprised a total of 52 patients; 28 patients received PSL, and 24 patients received ICD electrodes. A non-significant increase in the degree of TR was observed in patients who underwent new ICD lead implantation (P = .059). The degree of TR observed in patients who underwent new PSL implantation was found to be comparable to the pre-procedure levels (P = .180). However, no statistically significant differences were observed between the 2 groups with respect to change in TR degree (P = .123). Conclusion: This study is the first analysis comparing the effect of ICD electrode addition with PSL addition without lead extraction on right ventricular and tricuspid valve function in patients with lead failure. This study provides the first comparative analysis of PSL versus ICD lead addition in patients with lead failure. The findings suggest that additional leads, whether PSL or ICD, do not significantly worsen tricuspid valve function. The addition of PSL to the IS-1/DF-1 ICD lead with standard high-voltage leads may be a viable treatment option, as it yields similar results to a new ICD lead implantation in terms of right heart function.
- Open Access
- 6 October 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (5) , 748-754
Successful management of sudden cardiac arrest in an adolescent with arrhythmogenic right ventricular cardiomyopathy
Background. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a fatal, genetically transmitted cardiomyopathy that can cause unpredictable malignant life-threatening arrhythmias. Arrhythmias that may be hemodynamically insignificant in healthy persons, yet may be fatal in patients with cardiomyopathy and end-stage heart failure. Thus, urgent and prompt management of arrhythmias in these patients is essential to achieve favorable outcomes. Case Presentation. Here, we present a 13-year-old male who was referred to our institution with a prediagnosis of ARVC and had sudden cardiac arrest on the second day due to ventricular tachycardia / fibrillation. Successful extracorporeal cardiopulmonary resuscitation (E-CPR) was performed. A successful endo-epicardial ablation of ventricular tachycardia and implantable cardiac defibrillator insertion were performed under extracorporeal membrane oxygenation (ECMO) due to recurrent malignant ventricular arrhythmias. On the fourth day, he was weaned from ECMO without any sequelae. Although the patient did not experience any hemodynamically significant or sustained tachycardia after catheter ablation, he underwent a successful transplantation due to progressive heart failure. Conclusion. Appropriate and urgent management of life-threatening arrhythmias and when necessary high-quality resuscitation measures including E-CPR and a multidisciplinary coordinated approach is crucial in the management of patients with cardiomyopathy and end-stage heart failure.
- 6 October 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (5) , 748-754
Open AccessSuccessful management of sudden cardiac arrest in an adolescent with arrhythmogenic right ventricular cardiomyopathy
Background. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a fatal, genetically transmitted cardiomyopathy that can cause unpredictable malignant life-threatening arrhythmias. Arrhythmias that may be hemodynamically insignificant in healthy persons, yet may be fatal in patients with cardiomyopathy and end-stage heart failure. Thus, urgent and prompt management of arrhythmias in these patients is essential to achieve favorable outcomes. Case Presentation. Here, we present a 13-year-old male who was referred to our institution with a prediagnosis of ARVC and had sudden cardiac arrest on the second day due to ventricular tachycardia / fibrillation. Successful extracorporeal cardiopulmonary resuscitation (E-CPR) was performed. A successful endo-epicardial ablation of ventricular tachycardia and implantable cardiac defibrillator insertion were performed under extracorporeal membrane oxygenation (ECMO) due to recurrent malignant ventricular arrhythmias. On the fourth day, he was weaned from ECMO without any sequelae. Although the patient did not experience any hemodynamically significant or sustained tachycardia after catheter ablation, he underwent a successful transplantation due to progressive heart failure. Conclusion. Appropriate and urgent management of life-threatening arrhythmias and when necessary high-quality resuscitation measures including E-CPR and a multidisciplinary coordinated approach is crucial in the management of patients with cardiomyopathy and end-stage heart failure.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 217-225
Impact of obesity and prognostic nutritional index on outcomes of ventricular tachycardia ablation in patients with structural heart disease
Objectives: Previous studies have demonstrated that nutritional disorders such as obesity and malnutrition are associated with adverse events in patients with a structural heart disease. The impact of these conditions in patients undergoing ventricular tachycardia (VT) ablation is not known. In this study we sought to investigate the effect of obesity and malnutrition on procedural and post-procedural midterm outcomes in patients undergoing VT ablation. Materials and methods: This is a single center, retrospective study which enrolled patients undergoing structural VT ablation. Patients were classified as normal weight, overweight and obese by body mass index (BMI). Malnutrition was defined as prognostic nutritional score (PNI) < 38. Outcomes between groups were compared. Results: A total of 203 patients were enrolled to this study. Among these patients, 54 (25.6%) were normal weight, 102 patients (50.2%) were overweight, and 47 patients (23.1%) were obese. 18 patients (8.8%) were classified as malnourished. No significant difference in VT recurrence was observed across BMI (p=0.335) or nutritional status (p=0.556). However, mortality during follow-up was significantly higher in the malnourished group (50% vs. 7%, p
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 217-225
Impact of obesity and prognostic nutritional index on outcomes of ventricular tachycardia ablation in patients with structural heart disease
Objectives: Previous studies have demonstrated that nutritional disorders such as obesity and malnutrition are associated with adverse events in patients with a structural heart disease. The impact of these conditions in patients undergoing ventricular tachycardia (VT) ablation is not known. In this study we sought to investigate the effect of obesity and malnutrition on procedural and post-procedural midterm outcomes in patients undergoing VT ablation. Materials and methods: This is a single center, retrospective study which enrolled patients undergoing structural VT ablation. Patients were classified as normal weight, overweight and obese by body mass index (BMI). Malnutrition was defined as prognostic nutritional score (PNI) < 38. Outcomes between groups were compared. Results: A total of 203 patients were enrolled to this study. Among these patients, 54 (25.6%) were normal weight, 102 patients (50.2%) were overweight, and 47 patients (23.1%) were obese. 18 patients (8.8%) were classified as malnourished. No significant difference in VT recurrence was observed across BMI (p=0.335) or nutritional status (p=0.556). However, mortality during follow-up was significantly higher in the malnourished group (50% vs. 7%, p
- 23 July 2025
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 137 (6) , 543-551
Systemic immune-inflammatory index and other inflammatory markers in electrical storm vs. patients undergoing elective ventricular tachycardia ablation
Ventricular arrhythmias (VA) are a major cause of sudden cardiac death (SCD) in heart failure patients. It is not known whether readily available clinical markers are of any clinical yield in detecting a subclinical inflammation that may be inflicted in acute arrhythmogenesis. This study aimed to evaluate the prognostic value of inflammatory markers in patients undergoing ventricular tachycardia (VT) catheter ablation and to compare characteristics between those with electrical storm (ES) and elective ablation (EL). This retrospective observational study included patients with structural heart disease undergoing VT ablation. Inflammatory markers (CRP, blood leukocyte, neutrophil, platelet, lymphocyte counts and systemic immune-inflammatory index (SII)) were assessed pre-procedurally. We analyzed procedural outcomes, VT recurrence, mid-term mortality and presence of an electrical storm, correlating these with inflammatory markers. p < 0.05 was considered significant in all analyses. Of 140 patients analyzed (median age 65 ± 15 years; 87.1% males), 63 (45%) had ES and 77(55%) underwent elective ablation. The median ejection fraction was 25%±15.The ES group had significantly higher neutrophil counts and systemic immune-inflammation index (SII) compared to the EL group (p = 0.010 and p = 0.013, respectively). On univariate analysis, elevated SII was associated with mid-term mortality (HR 3.487, p = 0.016), alongside age > 70 years and history of coronary artery bypass grafting (CABG). SII and history of CABG were independent predictors of death on multivariate analysis (HR 1.879, p = 0.018) and (HR: 4.891, p = 0.003), respectively. SII is notably higher in those experiencing ES and is a predictor of mid-term mortality.
- 23 July 2025
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 137 (6) , 543-551
Systemic immune-inflammatory index and other inflammatory markers in electrical storm vs. patients undergoing elective ventricular tachycardia ablation
Ventricular arrhythmias (VA) are a major cause of sudden cardiac death (SCD) in heart failure patients. It is not known whether readily available clinical markers are of any clinical yield in detecting a subclinical inflammation that may be inflicted in acute arrhythmogenesis. This study aimed to evaluate the prognostic value of inflammatory markers in patients undergoing ventricular tachycardia (VT) catheter ablation and to compare characteristics between those with electrical storm (ES) and elective ablation (EL). This retrospective observational study included patients with structural heart disease undergoing VT ablation. Inflammatory markers (CRP, blood leukocyte, neutrophil, platelet, lymphocyte counts and systemic immune-inflammatory index (SII)) were assessed pre-procedurally. We analyzed procedural outcomes, VT recurrence, mid-term mortality and presence of an electrical storm, correlating these with inflammatory markers. p < 0.05 was considered significant in all analyses. Of 140 patients analyzed (median age 65 ± 15 years; 87.1% males), 63 (45%) had ES and 77(55%) underwent elective ablation. The median ejection fraction was 25%±15.The ES group had significantly higher neutrophil counts and systemic immune-inflammation index (SII) compared to the EL group (p = 0.010 and p = 0.013, respectively). On univariate analysis, elevated SII was associated with mid-term mortality (HR 3.487, p = 0.016), alongside age > 70 years and history of coronary artery bypass grafting (CABG). SII and history of CABG were independent predictors of death on multivariate analysis (HR 1.879, p = 0.018) and (HR: 4.891, p = 0.003), respectively. SII is notably higher in those experiencing ES and is a predictor of mid-term mortality.
- Open Access
- 2 June 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (7) , 672-681
Fascicular/Purkinje Tissue Colocalized With Scar in Cardiomyopathy Patients Undergoing Ventricular Fibrillation Ablation
Background: Ventricular fibrillation (VF) is a poorly understood arrhythmia that is one of the main mechanisms of sudden cardiac death in patients with structural heart disease (SHD). Fascicular and Purkinje tissue (FPT) has been implicated in VF. Objective: In this study, we sought to analyze the involvement of FPT colocalized with the scar area of SHD. Additionally, we aimed to investigate outcomes of FPT and scar substrate ablation in SHD VF patients and compare outcomes with VT ablation patients. Methods: This is a retrospective observational study. Clinical and procedural data were collected. Results: Sixteen patients undergoing VF ablation were assigned to the VF group, and their outcomes were compared to those of 170 patients who underwent structural VT ablation. In 15 patients, FPT targets colocalized with low voltage area, LPs, and/or LAVAs. Septal Purkinje and left posterior fascicle were most commonly involved. Procedural metrics were similar with patients undergoing VT ablation. During median follow‐up of 5.5 months (interquartile range [IQR]: 3.5–10), VF recurred in two patients. Conclusion: This study has shown frequent colocalization of FPT with electrophysiologic substrate (late potentials [LPs], low voltage area, etc.) in patients with SHD and VF. We have shown the feasibility of FTP and substrate ablation with good mid‐term outcomes in a small group of patients. Larger studies are necessary for definitive evidence.
- 2 June 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (7) , 672-681
Open AccessFascicular/Purkinje Tissue Colocalized With Scar in Cardiomyopathy Patients Undergoing Ventricular Fibrillation Ablation
Background: Ventricular fibrillation (VF) is a poorly understood arrhythmia that is one of the main mechanisms of sudden cardiac death in patients with structural heart disease (SHD). Fascicular and Purkinje tissue (FPT) has been implicated in VF. Objective: In this study, we sought to analyze the involvement of FPT colocalized with the scar area of SHD. Additionally, we aimed to investigate outcomes of FPT and scar substrate ablation in SHD VF patients and compare outcomes with VT ablation patients. Methods: This is a retrospective observational study. Clinical and procedural data were collected. Results: Sixteen patients undergoing VF ablation were assigned to the VF group, and their outcomes were compared to those of 170 patients who underwent structural VT ablation. In 15 patients, FPT targets colocalized with low voltage area, LPs, and/or LAVAs. Septal Purkinje and left posterior fascicle were most commonly involved. Procedural metrics were similar with patients undergoing VT ablation. During median follow‐up of 5.5 months (interquartile range [IQR]: 3.5–10), VF recurred in two patients. Conclusion: This study has shown frequent colocalization of FPT with electrophysiologic substrate (late potentials [LPs], low voltage area, etc.) in patients with SHD and VF. We have shown the feasibility of FTP and substrate ablation with good mid‐term outcomes in a small group of patients. Larger studies are necessary for definitive evidence.
- Open Access
- 23 August 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (5) , 810-812
Cardioneuroablation for carotid sinus syndrome mediated by complete atrioventricular block
Carotid sinus syndrome (CSS) is a rare condition leading to recurrent syncope. Permanent pacemaker implantation is the mainstay treatment of cardioinhibitory CSS. In this report, we present a CSS patient with reproducible atrioventricular block during carotid massage, who was treated with cardioneuroablation.
- 23 August 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (5) , 810-812
Open AccessCardioneuroablation for carotid sinus syndrome mediated by complete atrioventricular block
Carotid sinus syndrome (CSS) is a rare condition leading to recurrent syncope. Permanent pacemaker implantation is the mainstay treatment of cardioinhibitory CSS. In this report, we present a CSS patient with reproducible atrioventricular block during carotid massage, who was treated with cardioneuroablation.
- 22 February 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 66 (8) , 1901-1910
Electrophysiological characteristics of epicardial atrial tachycardias and endocardial breakthrough site targeting for ablation: a single center experience
Background Despite being increasingly observed in daily practice, epicardial atrial tachycardias (Epi AT) have not been extensively characterized. In the present study, we retrospectively characterize electrophysiological properties, electroanatomic ablation targeting, and outcomes of this ablation strategy. Methods Patients who underwent scar-based macro-reentrant left atrial tachycardia mapping and ablation patients with at least one Epi AT, which had a complete endocardial map, were selected for the inclusion. Based on current electroanatomical knowledge, Epi ATs were classified based by utilization of following epicardial structures: Bachmann’s bundle, septopulmonary bundle, vein of Marshall. Endocardial breakthrough (EB) sites were analyzed as well as entrainment parameters. EB site was targeted for initial ablation. Results Among seventy-eight patients undergoing scar-based macro-reentrant left atrial tachycardia ablation, fourteen (17.8%) patients met the inclusion criteria for Epi AT and were included in the study. Sixteen Epi ATs were mapped, four utilizing Bachmann’s bundle, five utilizing septopulmonary bundle, and seven utilizing vein of Marshall. Fractionated, low amplitude signals were present at EB sites. Rf terminated the tachycardia in ten patients; activation changed in five patients and in one patient atrial fibrillation ensued. During the follow-up, there were three recurrences. Conclusions Epicardial left atrial tachycardias are a distinct type of macro-reentrant tachycardias that can be characterized by activation and entrainment mapping, without need for epicardial access. Endocardial breakthrough site ablation reliably terminates these tachycardias with good long-term success.
- 22 February 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 66 (8) , 1901-1910
Electrophysiological characteristics of epicardial atrial tachycardias and endocardial breakthrough site targeting for ablation: a single center experience
Background Despite being increasingly observed in daily practice, epicardial atrial tachycardias (Epi AT) have not been extensively characterized. In the present study, we retrospectively characterize electrophysiological properties, electroanatomic ablation targeting, and outcomes of this ablation strategy. Methods Patients who underwent scar-based macro-reentrant left atrial tachycardia mapping and ablation patients with at least one Epi AT, which had a complete endocardial map, were selected for the inclusion. Based on current electroanatomical knowledge, Epi ATs were classified based by utilization of following epicardial structures: Bachmann’s bundle, septopulmonary bundle, vein of Marshall. Endocardial breakthrough (EB) sites were analyzed as well as entrainment parameters. EB site was targeted for initial ablation. Results Among seventy-eight patients undergoing scar-based macro-reentrant left atrial tachycardia ablation, fourteen (17.8%) patients met the inclusion criteria for Epi AT and were included in the study. Sixteen Epi ATs were mapped, four utilizing Bachmann’s bundle, five utilizing septopulmonary bundle, and seven utilizing vein of Marshall. Fractionated, low amplitude signals were present at EB sites. Rf terminated the tachycardia in ten patients; activation changed in five patients and in one patient atrial fibrillation ensued. During the follow-up, there were three recurrences. Conclusions Epicardial left atrial tachycardias are a distinct type of macro-reentrant tachycardias that can be characterized by activation and entrainment mapping, without need for epicardial access. Endocardial breakthrough site ablation reliably terminates these tachycardias with good long-term success.
- Open Access
- 1 August 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (8) , 629-636
Procedural Characteristics, Safety, and Follow-up of Modified Right-Sided Approach for Cardioneuroablation
Cardioneuroablation is one of the emerging therapies in vasovagal syncope. In this study, we present a simple method of cardioneuroablation performed via a right-sided approach, targeting anterior-right and right-inferior ganglionated plexi, along with procedural and follow-up data. Patients who had underwent cardioneuroablation between March 2018 and September 2019 with vasovagal syncope in 2 clinics were enrolled in the study. All patients underwent radio-anatomically guided radiofrequency ablation targeting anterior-right ganglionated plexi and right-inferior ganglionated plexi. Syncope and symptom burden, 24-hour ambulatory electrocardiogram data at presentation, and at follow-up were assessed along with procedural data. A total of 23 patients underwent modified right-sided cardioneuroablation. Mean basal cycle length decreased significantly from 862.3 ± 174.5 ms at the beginning of the procedure 695.8 ± 152.1 ms following the final radiofrequency ablation (P < .001). Mean 24-hour ambulatory heart rate increased significantly from 66.4 ± 10.7 bpm at baseline to 80 ± 7.6 bpm at follow-up (P < .001). Only 1 patient had 1 episode of syncope following the procedure at the mean follow-up period of 10 ± 2.9 months. The same patient had recurrent presyncope. The right-sided cardioneuroablation approach was found to be an effective treatment for vasovagal syncope and may be regarded as a default initial cardioneuroablation technique.
- 1 August 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (8) , 629-636
Open AccessProcedural Characteristics, Safety, and Follow-up of Modified Right-Sided Approach for Cardioneuroablation
Cardioneuroablation is one of the emerging therapies in vasovagal syncope. In this study, we present a simple method of cardioneuroablation performed via a right-sided approach, targeting anterior-right and right-inferior ganglionated plexi, along with procedural and follow-up data. Patients who had underwent cardioneuroablation between March 2018 and September 2019 with vasovagal syncope in 2 clinics were enrolled in the study. All patients underwent radio-anatomically guided radiofrequency ablation targeting anterior-right ganglionated plexi and right-inferior ganglionated plexi. Syncope and symptom burden, 24-hour ambulatory electrocardiogram data at presentation, and at follow-up were assessed along with procedural data. A total of 23 patients underwent modified right-sided cardioneuroablation. Mean basal cycle length decreased significantly from 862.3 ± 174.5 ms at the beginning of the procedure 695.8 ± 152.1 ms following the final radiofrequency ablation (P < .001). Mean 24-hour ambulatory heart rate increased significantly from 66.4 ± 10.7 bpm at baseline to 80 ± 7.6 bpm at follow-up (P < .001). Only 1 patient had 1 episode of syncope following the procedure at the mean follow-up period of 10 ± 2.9 months. The same patient had recurrent presyncope. The right-sided cardioneuroablation approach was found to be an effective treatment for vasovagal syncope and may be regarded as a default initial cardioneuroablation technique.
- Open Access
- 31 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (6) , 485-491
Long-Term Results of Pulmonary Vein Isolation Plus Modified Posterior Wall Debulking Utilizing High-Power Short-Duration Strategy: An All-Comers Study in Real World
Background: High-power short-duration radiofrequency ablation has improved lesion durability in pulmonary vein isolation. In this study, we investigate long-term clinical outcomes of high-power short-duration pulmonary vein isolation and posterior wall debulking as an initial treatment modality in all corner atrial fibrillation patients. Methods: This is a single-center, retrospective, observational study including all patients who have undergone high-power short-duration pulmonary vein and posterior wall debulking, regardless of atrial fibrillation type and/or duration. High-power short-duration power delivery protocol was defined as 45 W at all ablation sites. Clinical and electrocardiographic follow-up were performed in all patients. Results: One hundred forty-two patients were enrolled in this study. Paroxysmal atrial fibrillation was present in 88 (62%) of patients. The mean follow-up of this study was 36.9 months +/- 12.2 months. During the follow-up period, 10 patients (11.4%) with a diagnosis of paroxysmal atrial fibrillation had recurrence, while recurrence in patients with persistent and long-standing persistent atrial fibrillation was slightly higher (15 patients (28.1%) and 5 patients (50%), respectively). No major life-threatening complications occurred. Conclusion: This study has demonstrated excellent arrhythmia-free outcomes in unselected, real world atrial fibrillation patients undergoing high-power short-duration pulmonary vein and debulking posterior wall isolations, however larger randomized trials are warranted.
- 31 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (6) , 485-491
Open AccessLong-Term Results of Pulmonary Vein Isolation Plus Modified Posterior Wall Debulking Utilizing High-Power Short-Duration Strategy: An All-Comers Study in Real World
Background: High-power short-duration radiofrequency ablation has improved lesion durability in pulmonary vein isolation. In this study, we investigate long-term clinical outcomes of high-power short-duration pulmonary vein isolation and posterior wall debulking as an initial treatment modality in all corner atrial fibrillation patients. Methods: This is a single-center, retrospective, observational study including all patients who have undergone high-power short-duration pulmonary vein and posterior wall debulking, regardless of atrial fibrillation type and/or duration. High-power short-duration power delivery protocol was defined as 45 W at all ablation sites. Clinical and electrocardiographic follow-up were performed in all patients. Results: One hundred forty-two patients were enrolled in this study. Paroxysmal atrial fibrillation was present in 88 (62%) of patients. The mean follow-up of this study was 36.9 months +/- 12.2 months. During the follow-up period, 10 patients (11.4%) with a diagnosis of paroxysmal atrial fibrillation had recurrence, while recurrence in patients with persistent and long-standing persistent atrial fibrillation was slightly higher (15 patients (28.1%) and 5 patients (50%), respectively). No major life-threatening complications occurred. Conclusion: This study has demonstrated excellent arrhythmia-free outcomes in unselected, real world atrial fibrillation patients undergoing high-power short-duration pulmonary vein and debulking posterior wall isolations, however larger randomized trials are warranted.